Skip to main content

Table 1 Characteristics of patients in study groups

From: Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

Feature

*BOT cases, n=102 (%)

Ovarian cancer G1 cases, n=167 (%)

Mean age at diagnosis (range)

47.76 (17–83)

54.25 (19–84)

Mean follow up in months (range)

126 (10–528)

82 (1–216)

The histological type of tumor

 Serous

61 (59.8%)

79 (47.3%)

 Mucinous

22 (21.6%)

38 (22.8%)

 Endometrioid

0 (0%)

36 (21.6%)

 Clear-cell

0 (0%)

2 (1.2%)

 Other or undefined/mixed

1 (0.1%)

2 (1.2%)

 Missing

18 (17.6%)

10 (6.0%)

Family history of OC

 Yes

12 (11.8%)

8 (4.8%)

 No

88 (86.3%)

152 (91.0%)

 Missing

2 (2.0%)

7 (4.2%)

Death

 Yes

10 (9.8%)

44 (26.3%)

 No

88 (86.3%)

113 (67.7%)

 Missing

4 (3.9%)

10 (6.0%)

  1. *BOT borderline ovarian tumor